Skip to main content
. 2013 Oct 10;8(10):e77479. doi: 10.1371/journal.pone.0077479

Figure 2. Changes in CMV-Sp-CD4 T cell response.

Figure 2

(2a) Mean (95%CI) change in CMV-Sp-CD4 (% of CD4 T cells) when compared to baseline over 96 weeks of ART based on a random effects regression model (* P<0.05). (2B) Mean (95%CI) change in absolute CMV-Sp-CD4 count (cells/mL) when compared to baseline over 96 weeks of ART based on a random effects regression model (* P<0.05).